MétaCan
Menu
Back to cohort
Record W2980254259

The Appropriate Use of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting Surgery

2019· article· en· W2980254259 on OpenAlexaboutno aff
Saurabh Gupta

Bibliographic record

VenueMacSphere (McMaster University) · 2019
Typearticle
Languageen
FieldMedicine
TopicAntiplatelet Therapy and Cardiovascular Diseases
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineBypass graftingArteryCardiologySurgeryCoronary artery bypass surgeryInternal medicine
DOInot available

Abstract

fetched live from OpenAlex

Dual antiplatelet therapy (DAPT) is a combination of acetylsalicylic acid (ASA) and a P2Y12 inhibitor recommended for patients suffering from an acute coronary syndrome (ACS). Guidelines now recommend the use of ticagrelor – instead of clopidogrel – in combination with ASA to treat ACS patients, regardless of management strategy. Unfortunately, at a rate of approximately 80%, clopidogrel remains the most commonly prescribed P2Y12 inhibitor across Canada, while ticagrelor lags far behind at only 9%. More specifically, while cardiac surgeons appropriately stop DAPT pre-operatively to reduce risk of bleeding, they remain hesitant to resume the regimen post-operatively. \nThis thesis comprises five chapters that use the practicing knowledge translation (PKT) framework to address the lack of uptake and guideline adherence around antiplatelet therapy amongst coronary artery bypass grafting (CABG) patients. It demonstrates that DAPT with ASA and ticagrelor is the best regimen to reduce mortality and major adverse cardiovascular events (MACE), and discusses the next steps required – as per the PKT framework – to highlight the gaps in evidence and practice that exist across the province of Ontario. \nChapter 1 is a preface that provides the rationale for this thesis, and how it fits into the PKT framework. \nChapter 2 has been published in the journal Canadian Journal of Cardiology. A review of the current literature is presented, highlighting that although available guidelines recommend DAPT with ASA and ticagrelor for ACS patients undergoing CABG, the evidence for this is limited and generated from small randomized controlled trials (RCTs) with significant heterogeneity or sub-studies of larger RCTs. \nChapter 3 has been accepted for publication in the journal Medicine. A protocol for a systematic review and network meta-analysis is presented, evaluating various antiplatelet regimens for CABG patients. \nChapter 4 will be published as an abstract in the journal Canadian Journal of Cardiology and presented at the Canadian Cardiovascular Congress 2019. The manuscript will be submitted to the journal Journal of the American College of Cardiology. It is a systematic review and network meta-analysis of over 15 511 CABG patients demonstrating the efficacy and safety of DAPT with ASA and ticagrelor in reducing mortality, MACE, and graft obstruction. By performing a network meta-analysis, a narrower confidence in the efficacy and safety estimates of DAPT with ASA and ticagrelor was developed. \nChapter 5 presents the conclusions of my thesis, and the next steps that must be taken as per the PKT framework.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.013
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Other · Consensus signal: none
Teacher disagreement score0.151
Threshold uncertainty score0.299

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.013
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.002
Scholarly communication0.0030.001
Open science0.0010.001
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0070.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.191
Teacher spread0.175 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreOther

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueMacSphere (McMaster University)Same topicAntiplatelet Therapy and Cardiovascular DiseasesFrench-language works237,207